medigraphic.com
ISSN 2448-8909 (Print)

2002, Number 6

<< Back Next >>

Med Crit 2002; 16 (6)

Chronic obstructive pulmonary disease. Current treatment

Pérez CR

Language: Spanish
References: 19
Page: 211-215
PDF size: 51.80 Kb.


ABSTRACT

Chronic obstructive pulmonary disease (COPD) is the name of a group of chronic and slowly progressive respiratory disorders characterized by reduced maximal expiratory flow during forced exhalation. COPD is the fourth leading cause of death in the United States. Cigarette smoking, air pollution, occupational exposures to either organic or inorganic dust and noxious gases, and α1 antitrypsyn deficiency are the risk factors linked to COPD. Airflow limitation, hyperinflation, impaired gas exchange and pulmonary circulation malfunction are present in patients with COPD. The evaluation of COPD is on the basis of history, radiographic studies and pulmonary function tests; physical examination has poor sensitivity.


REFERENCES

  1. Mcphee SJ, Ganong WF, Lingappa VR, Lange JD. Fisiopatología de enfermedades pulmonares seleccionadas. Fisiopatología Médica 1999:182-183.

  2. Tierney LM, Mcphee SJ, Papadakis MA. Enfermedad pulmonar obstructiva crónica. Diagnóstico clínico y tratamiento, 2001:278-279.

  3. Mahler DA. Dyspnea. Diagnosis and management. Clin Chest Med 1987;8:215-230.

  4. Owens G, Rogers R, Pennock B, Levin D. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med 1998;310-1218.

  5. Crapo-RO, Forster RE. Carbon monoxide diffusing capacity. Clin Chest Med 1989;10:187.

  6. Miller RR, Muller NL, Vedal S, Morrison NJ, Slaples CA. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989;139:980-3.

  7. Haluszka J, Chartrand DA, Grassino AE, Milic-Emili J. Intrinsic PEEP and arterial PCO2 in stable patients with Chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:1194-7.

  8. Stanesw D, Sanna A, Veriter C, Kostrioner S, Calcani PG, Fabbri LM et al. Airsways obstruction chronic expectoration, and rapid decline of FEV, in smokers are associated with increased levels of sputum neutrophilis. Thorax 1996;51:267-71.

  9. Anthonisen NR, Conne JE, Kiley JP, Altose MD, Bailey WC, Borst AS. Effects of smoking intervention and the use of and inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study. JAMA 1994;272:1497-505.

  10. Dubois P, Jamart J, Machiels J, Smects F, Luling J. Prognosis of severely hypoxemic patients receiving long-term oxygen treatment. Chest 1994;105:469-14.

  11. Mohsenin V, Guffanti EE, Hilert J, Ferranti R. Daylie oxygen saturation does not predict nocturnal oxigen desaturation in patients with chonic obstructive pulmonary disease. Arch Phys Med Rehabil 1994;75:285-9.

  12. Albert R. Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? Am J Respir Crit Care Med 1997;155:784-5.

  13. Fishman AP. Pulmonary rehabilitation research. Am J Respir Crit Care Med 1994;149:825-33.

  14. Hill NS. Noninvasive ventilation: does it work, for whom, and how? Am Rev Respir Dis 1993;147:1050-5.

  15. Annest LS, Kratz JM, Crawford FA Jr. Current results of treatment of bronchiectosis. J Thorac Cardiovasc Surg 1999;83:546-50.

  16. Hamid Q, Azzawi M, Ying S, Mogbel R, Wardlaw AJ, Corrigan LJ et al. Expression of mARN for interteukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 2000;87:1541-6.

  17. Feld RD. Heterozygosity of alpha 1-antitrypsin: a hearth risk? Crit Rey Clin Lab 1999;27:461-81.

  18. Lee KS, Kullning P, Hartman TE, Muller NL. Cryptogonic organizing pneumonia: CT findings in 43 patients. AJR Am J Roentgenol 1999;162:543-6.

  19. Wenzel SE. Asthma an inflammatory disease. Ann Allergy 1999; 72: 261-72.




2020     |     www.medigraphic.com